Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects

被引：0
|
作者：
Adelaida Morte
Anna Vaqué
Marc Iniesta
Barbara Schug
Cornelius Koch
Rafael De la Torre
Bjoern Schurad
机构：
[1] ESTEVE Pharmaceuticals SA,
[2] SocraTec R&D GmbH,undefined
[3] Grup de Recerca en Farmacologia Integrada i Neurociencia de Sistemes,undefined
[4] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),undefined
[5] Luye Pharma AG,undefined
[6] Luye Pharma Switzerland AG,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2022年 / 47卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：567 / 578
页数：11
相关论文
共 50 条
  • [41] Comparative bioavailability study of two preparations of letrozole in healthy subjects
    Dyderski, S
    Grzeskowiak, E
    Szalek, E
    Szkutnik, D
    Dubai, V
    Drobnik, L
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (09): : 514 - 519
  • [42] RELATIVE BIOAVAILABILITY OF A VINCAMINE RETARD FORMULATION - PHARMACOKINETIC STUDY IN NORMAL SUBJECTS
    ERKING, W
    LUCKER, PW
    METZ, G
    SPECKER, M
    WETZELSBERGER, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1978, 28-2 (12): : 2332 - 2336
  • [43] Pharmacokinetic study of the transdermal delivery system, TDS©-testosterone in healthy subjects
    Chik, Z
    Johnston, A
    Tucker, AT
    Chew, SL
    Alam, CAS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 636 - 636
  • [44] IDEAL: A 6-month placebo-controlled study of the first transdermal patch in Alzheimer's disease rivastigmine patch versus capsule
    Winblad, Bengt
    Cummings, Jeffrey
    Zechner, Stefanie
    Ros, Jacqueline
    Nagel, Jennifer
    Bernhard, Gudrun
    Lane, Roger
    ANNALS OF NEUROLOGY, 2006, 60 : S56 - S56
  • [45] The Relative Bioavailability, Food Effect, and Drug Interaction With Omeprazole of Momelotinib Tablet Formulation in Healthy Subjects
    Xin, Yan
    Shao, Lixin
    Maltzman, Julie
    Stefanidis, Dimitrios
    Hemenway, Jeffrey
    Tarnowski, Thomas
    Deng, Wei
    Silverman, Jeffrey A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (03): : 277 - 286
  • [46] Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects
    Patel, Parul
    Song, Ivy
    Borland, Julie
    Chen, Shuguang
    Peppercorn, Amanda
    Wajima, Toshihiro
    Funaki, Takeshi
    Fujita, Naomi
    Hughes, John
    Piscitelli, Stephen
    ANTIVIRAL THERAPY, 2014, 19 (03) : 229 - 233
  • [47] The absolute bioavailability of an oral sustained-release formulation of desvenlafaxine succinate in healthy subjects.
    Parker, VD
    Richards, LS
    Nichols, AI
    Behrle, JA
    Fruncillo, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P47 - P47
  • [48] PATCH AND PRICK TEST STUDY OF 593 HEALTHY-SUBJECTS
    SEIDENARI, S
    MANZINI, BM
    DANESE, P
    MOTOLESE, A
    CONTACT DERMATITIS, 1990, 23 (03) : 162 - 167
  • [49] The Bioavailability and Pharmacokinetics of Silymarin SMEDDS Formulation Study in Healthy Thai Volunteers
    Sornsuvit, Chuleegone
    Hongwiset, Darunee
    Yotsawimonwat, Songwut
    Toonkum, Manatchaya
    Thongsawat, Satawat
    Taesotikul, Wandee
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [50] Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease
    Cagnin, Annachiara
    Cester, Alberto
    Costa, Bruno
    Ermani, Mario
    Gabelli, Carlo
    Gambina, Giuseppe
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 457 - 463
12345